Genetic variations in human benign prostatic hyperplasia detected by restriction landmark genomic scanning

Journal of Urology

Volumn 157, Issue 4, 1997, Pages 1499-1503

  Konishi, Noboru ^a   Hiasa, Yoshio ^a   Matsuda, Hirofumi ^a   Nakamura, Mitsutoshi ^a   Kitahori, Yoshiteru ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

genome; human prostatic hyperplasia; RLGS

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DNA DETERMINATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RESTRICTION MAPPING;

EID: 0030892158     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65031-6     Document Type: Article

References (27)

1. White, J. J., Neuwirth, H., Miller, C. D. and Schneider, E. L.: DNA alterations in prostatic adenocarcinoma and benign prostatic hyperplasia: detection by DNA fingerprint analyses. Mutat. Res., 237: 37, 1990.
2. Bedford, M. T. and van Helden, P. D.: Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res., 47: 5274, 1987.
3. Muller, W. J., Lee, F. S., Dickson, C., Peters, G., Pattengale, P. and Leder, P.: The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J., 9: 907, 1990.
4. Tutrone, R. F., Jr., Ball, R. A., Ornitz, D. M., Leder, P. and Richie, J. P.: Benign prostatic hyperplasia in a transgenic mouse: a new hormonally sensitive investigatory model. J. Urol., 149: 633, 1993.
5. Mori, H., Maki, M., Oishi, K., Jaye, M., Igarashi, K., Yoshida, O. and Hatanaka, M.: Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia. Prostate, 16: 71, 1990.
6. Chung, L. W. and Cunha, G. R.: Stromal-epithelial interactions: II. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme. Prostate, 4: 503, 1983.
7. Cunha, G. R., Shannon, J. M., Neubauer, B. L., Sawyer, L. M., Fujii, H., Taguchi, O. and Chung, L. W. K.: Mesenchym-epithelial interactions in sex differentiation. Hum. Genet., 58: 68, 1981.
8. Coffey, D. S. and Walsh, P. C.: Clinical and experimental studies of benign prostatic hyperplasia. Urol. Clin. North Am., 17: 461, 1990.
9. Griffiths, K. and Eaton, C. L.: The pathogenesis of BPH: role of hormones. Prog. Clin. Biol. Res., 386: 33, 1994.
10. Sanda, M. G., Beaty, T. H., Stutzman, R. E., Childs, B. and Walsh, P. C.: Genetic susceptibility of benign prostatic hyperplasia. J. Urol., 152: 115, 1994.
11. Hirotsune, S., Hatada, I., Komatsubara, H., Nagai, H., Kuma, K., Kobayakawa, K., Kawara, T., Nakagawara, A., Fujii, K., Mukai, T. and Hayashizaki, Y.: New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning method. Cancer Res., 52: 3642, 1992.
12. Nagai, H., Hirotsune, S., Komatsubara, H., Hatada, I., Mukai, T., Hayashizaki, Y. and Matsubara, K.: Genomic analysis of human hepatocellular carcinomas using restriction landmark genomic scanning. Cancer Detect. Prev., 17: 399, 1993.
13. Nagai, H., Ponglikitmongkol, M., Mita, E., Ohmachi, Y., Yoshikawa, H., Saeki, R., Yumoto, Y., Nakanishi, T. and Matsubara, K.: Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis. Cancer Res., 54: 1545, 1994.
14. Hirotsune, S., Hirose, K., Kataoka, H., Kuromitsu, J., Furuichi, Y., Muramatsu, M., Matsuda, Y., Hayashizaki, Y.: Spot mapping on the standard profile of restriction landmark genomic scanning (RLGS) of sorted chromosome 20 using methylation-insensitive enzyme. Genomics., 24: 593, 1994.
15. Blin, N. and Stafford, D. W.: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acid. Res., 3: 2303, 1976.
16. Hatada, I., Hayashizaki, Y., Hirotsune, S., Komatsubara, H. and Mukai, T.: A genomic scanning method for higher organism using restriction sites as landmarks. Proc. Natl. Acad. Sci. USA, 88: 9523, 1991.
17. Garrels, J. I.: The QUEST system for quantitative analysis of two-dimensional gels. J. Biol. Chem., 264: 5269, 1989.
18. Griffiths, K., Eaton, C. L., Harper, M. E., Peeling, B. and Davies, P.: Steroid hormones and the pathogenesis of benign prostatic hyperplasia. Eur. Urol. (Suppl), 20: 68, 1991.
19. Pagano, F., Zattoni, F., Vianello, F., Piazza, R. and Capitanio, G.: Is there a relationship between benign prostatic hyperplasia and prostatic cancer? Eur. Urol. (Suppl), 20: 31, 1991.
20. Bostwick, D. G.: High grade prostatic intraepithelial neoplasia. The most likely precursor of prostatic cancer. Cancer (Suppl), 75: 1823, 1995.
21. Jeffreys, A. J., Wilson, V. and Thein, S. L.: Hypervariable "mini-satellite" regions in human DNA. Nature (Lond.), 314: 67, 1985.
22. Lindsay, S. and Bird, A. P.: Use of restriction enzymes to detect potential sequences in mammalian DNA. Nature (Lond.), 327: 336, 1987.
23. Kawai, J., Hirose, K., Fushiki, S., Hirotsune, S., Ozawa, N., Hara, A., Hayashizaki, Y. and Watanabe, S.: Comparison of DNA methylation patterns among mouse cell lines by restriction landmark genomic scanning. Mol. Cellular Biol., 14: 7421, 1994.
24. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J-P. J., Davidson, N. E., Sidransky, D. and Baylin, S. B.: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525, 1995.
25. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B. and Sidransky, D.: 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686, 1995.
26. Storg, M. T., Sasse, J., Jacobs, S. C. and Lawson, R. K.: Prostatic growth factor: Purification and structural relationship to basic fibroblastic growth factor. Biochem., 26: 3843, 1987.
27. Dickson, C. and Peters, G.: Potential oncogene product related to growth factors. Nature (Lond.), 326: 833, 1987.